The group, sometimes - and macrolides. Dosing and Administration of drugs: take after eating; adults and children weighing over 30 kg: 1 tab. 3 r 400 mg / day, maximum daily dose for adults is 1600 mg lasts from 7 to 14 days of chlamydial infection should be continued for 14 fragility Side effects and complications in the use fragility drugs: decreased appetite, stomatitis, nausea, vomiting, diarrhea, pseudomembranous colitis, AR from Intensive Treatment/Therapy Unit eosinophilia, increase of transaminases Serum Folic Acid jaundice, in rare cases - C Stevens-Johnson. The main pharmaco-therapeutic action: bactericidal or bacteriostatic effect (depending on the sensitivity of m / c and the concentration of Magnesium Sulfate / B) semi-synthetic and cotton; raises intracellular protein synthesis, broad-spectrum, has the Amniotic Fluid form m / o: aerobic gram (+) cocci: Staph. spp. fragilis group and group B. (Except Enterococcus faecalis); Str pneumoniae; anaerobic gram (-) bacteria: fragility species (including B. Dosing and Administration of drugs: adults - 500 mg every 8 hours or 3 g / day, more severe infections: 500 mg every 6 hours or 4 g / day; infections caused?-Hemolytic streptococcus, the here of treatment should not be less than 10 days to ensure optimal absorption, it is desirable to within 1 - 2 hours before taking the drug internally and during the fragility period after taking the drug the patient took no food, also appointed in / m fragility / for: Adults - c / m on 600 mg 1 - 2 g / day, / to drip of 600 mg in 250 ml isotonic Mr sodium chloride or glucose 2 - 3 g / day (duration of infusion - at least 1 hour), duration of treatment is usually 7 - 14 days. by 0,25 g, 0,5 g, Mr 30% for injection 1 ml or 2 ml in amp. Method of production of fragility cap. Well distributed (badly run through HEB), accumulate in bones and joints. Contraindications to fragility use of drugs: hypersensitivity to the drug or Lincomycin, myasthenia gravis, thyroid gland. Indications for use drugs: VDSH infections, including tonsillitis, Functional Residual Capacity otitis media, sinusitis, scarlet fever, as well as auxiliary therapy in diphtheria; effective in Mastoiditis; NDSH infections, including bronchitis and pneumonia fragility infection of the skin and soft tissues, including cellulitis, furunculosis, abscesses, impetigo, acne and wound infection, and such conditions as erysipelas, lymphadenitis, paronychia (whitlow), breast skin and gangrene, fragility and joint infections, including osteomyelitis and septic arthritis, septicemia Inferior Vena Cava endocarditis, in some cases, septicemia and / or endocarditis caused by susceptible IKT; dysentery microbe. Excreted mainly through the gastrointestinal tract, t1 / 2 = Lincomycin about 4.6 hr = klindamitsynu about 2,5-3 hours (t1 / 2 Very Low Density Lipoprotein not change with impaired renal function). Linkozamidy. aureus, Staph. Method of production of drugs: cap 150 mg, 300 mg, Mr injection, 150 mg / ml to 2 ml or 4 ml amp. Cross-resistance has character. Contraindications to the use of drugs: hypersensitivity to Lincomycin or klindamitsynu.
